Ontology highlight
ABSTRACT:
SUBMITTER: Franco-Juarez EX
PROVIDER: S-EPMC10855535 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature
Franco-Juárez Edgar Xchel EX González-Villasana Vianey V Camacho-Moll María Elena ME Rendón-Garlant Luisa L Ramírez-Flores Patricia Nefertari PN Silva-Ramírez Beatriz B Peñuelas-Urquides Katia K Cabello-Ruiz Ethel Daniela ED Castorena-Torres Fabiola F Bermúdez de León Mario M
International journal of molecular sciences 20240201 3
Hepatocellular carcinoma (HCC) is among the main causes of death by cancer worldwide, representing about 80-90% of all liver cancers. Treatments available for advanced HCC include atezolizumab, bevacizumab, sorafenib, among others. Atezolizumab and bevacizumab are immunological options recently incorporated into first-line treatments, along with sorafenib, for which great treatment achievements have been reached. However, sorafenib resistance is developed in most patients, and therapeutical comb ...[more]